Lv3
352 积分 2023-11-03 加入
Cadonilimab combined with lenvatinib and transarterial chemoembolization for non-metastatic unresectable hepatocellular carcinoma: a multicenter, open-label, phase 2 study
1个月前
已完结
Nalbuphine reduces the incidence of emergence agitation in children undergoing Adenotonsillectomy: A prospective, randomized, double-blind, multicenter study
7个月前
已完结
An overview of KRAS G12D inhibitors: Expanding the therapeutic frontier of KRAS in targeting KRAS G12D using diverse therapeutic modalities
8个月前
已完结
Breakthrough in RAS targeting with pan-RAS(ON) inhibitors RMC-7977 and RMC-6236
9个月前
已完结
Pan-RAS inhibitors: Hitting multiple RAS isozymes with one stone
9个月前
已关闭
Pan-RAS inhibitor after KRASG12C treatment in pancreatic cancer?
9个月前
已完结
Nivolumab added to cisplatin and radiotherapy versus cisplatin and radiotherapy alone after surgery for people with squamous cell carcinoma of the head and neck at a high risk of relapse (GORTEC 2018-01 NIVOPOST-OP): a randomised, open-label, phase 3 trial
9个月前
已完结
Part1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation
9个月前
已完结
Breakthrough in RAS targeting with pan-RAS(ON) inhibitors RMC-7977 and RMC-6236
9个月前
已完结
Pan-RAS inhibitors: Hitting multiple RAS isozymes with one stone
9个月前
已完结
皖公网安备34019202002308
